Connect with us

Business

Merck pill could cut COVID risk in half but won’t be a ‘miracle’ cure for coronavirus, scientists say – ABC News

An antiviral pill developed by US drug maker Merck could halve the chances of dying or being hospitalised from COVID-19, but…

Published

on

Article feature image

An antiviral pill developed by US drug maker Merck could halve the chances of dying or being hospitalised for those most at risk of contracting severe COVID-19, with experts hailing it as a potential breakthrough in how the virus is treated.
Key points:

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending